36 Warren Street
5 articles with PrEP Biopharm
PrEP Biopharm Limited announces Successful Completion of PrEP-001 Toxicology Study enabling Phase 2b Field Study of PrEP-001 Against All Respiratory Viruses
PrEP Biopharm Limited, a private drug company developing treatments for respiratory infectious diseases, announced that it has successfully completed a 12-week toxicology study in dogs. There were no mortalities and no test item-related changes in clinical signs, body weights, food consumption, or other systemic nor macroscopic adverse
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.